Shree Ganesh Remedies Fact Sheet, Shree Ganesh Remedies Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Shree Ganesh Remedies Fact Sheet    (SGRL)


REVEALED: 3 "Super Smallcaps" You Didn't Know About


Here is the latest financial fact sheet of Shree Ganesh Remedies . For more details, see the Shree Ganesh Remedies quarterly results and Shree Ganesh Remedies share price and chart. For a sector overview, read our pharmaceuticals sector report.

SHREE GANESH REMEDIES Price History

Price Rs 420.3
Mkt Cap Rs m 4,205
Vol '000 7.1
P/E X  
P/CF X 32.9
EPS (TTM) Rs 0.0
% ch % 0.3
No. of shares m 10.01
% ch week % 0.9
% ch 1-mth % 19.0
% ch 12-mth % 234.8
52 week H/L Rs 503.0/115.7
(As on Sep 21, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SHREE GANESH REMEDIES Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
SHREE GANESH REMEDIES  EQUITY SHARE DATA
High RsNANA4876111 
Low RsNANA304254 
Sales per share (Unadj.) Rs141.1180.530.439.471.4 
Earnings per share (Unadj.) Rs9.924.05.27.011.7 
Diluted earnings per shareRs1.12.64.76.210.5 
Cash flow per share (Unadj.) Rs15.328.95.98.114.2 
Dividends per share (Unadj.) Rs001.001.251.50 
Adj. dividends per shareRs0.000.000.901.121.34 
Avg Dividend yield %NMNM2.62.11.8 
Book value per share (Unadj.) Rs127.1150.032.037.747.0 
Adj. book value per shareRs14.016.528.733.842.2 
Shares outstanding (eoy) m1.101.108.978.978.97 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x001.31.51.2 
Avg P/E ratio x007.48.57.1 
P/CF ratio (eoy) x006.67.35.8 
Price / Book Value ratio x001.21.61.8 
Dividend payout %0019.118.012.9 
Avg Mkt Cap Rs m00347530740 
No. of employees `000NANANANANA 
Total wages/salary Rs m911161629 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
SHREE GANESH REMEDIES  INCOME DATA
Net Sales Rs m155199273353640 
Other income Rs m45201239 
Total revenues Rs m159203292365679 
Gross profit Rs m19415287125 
Depreciation Rs m6561023 
Interest Rs m00125 
Profit before tax Rs m16396587136 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m513182431 
Profit after tax Rs m11264762105 
Gross profit margin %12.420.519.024.819.6 
Effective tax rate %33.633.127.628.123.0 
Net profit margin %7.013.317.217.716.4 
SHREE GANESH REMEDIES  BALANCE SHEET DATA
Current assets Rs m111166285258338 
Current liabilities Rs m15446568104 
Net working cap to sales %61.561.480.553.936.6 
Current ratio x7.33.74.43.83.3 
Inventory Days Days66685225 
Debtors Days Days13313577100101 
Net fixed assets Rs m464572155215 
Share capital Rs m1111909090 
"Free" reserves Rs m129154197249332 
Net worth Rs m140165287338422 
Long term debt Rs m002222 
Total assets Rs m157211356413553 
Interest coverage x38.095.065.143.526.0 
Debt to equity ratio x00000.1 
Sales to assets ratio x1.00.90.80.91.2 
Return on assets %7.212.713.415.619.9 
Return on equity %7.716.016.318.424.8 
Return on capital %12.024.222.826.031.8 
Exports to sales %071.969.270.473.4 
Imports to sales %017.221.421.230.9 
Exports (fob) Rs m0143189249470 
Imports (cif) Rs m0345875198 
Fx inflow Rs m0143189249470 
Fx outflow Rs m0345875198 
Net fx Rs m0109130173272 
SHREE GANESH REMEDIES  CASH FLOW
From Operations Rs m 0 0 -9 -52 46 
From Investments Rs m 0 0 -35 -1 -29 
From Financial Activity Rs m 0 0 81 -2 -5 
Net Cashflow Rs m 0 0 38 -55 12 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 68.4%
Institution 0.0%
Non-Institution 31.6%
Total 100.0%
Free Float 31.6%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF Plot No. 6011, G I D C, Ankleshwar - 393002
E-MAIL investors@ganeshremedies.com WEB www.ganeshremedies.com
TEL 02641 22777 FAX
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT Bigshare Services Pvt Ltd, Bharat Tin Works Building, 1st floor Opp. Vasant Oasis, Andheri (E)
YEAR OF INC: 1995 BSE CODE: 540737 FV (Rs): 10 DIV YIELD (%): 0.3

More Pharmaceuticals Company Fact Sheets:   VANTA BIOSCIENCE  SUNIL HEALTHCARE  NATCO PHARMA  ADVIK LABORS  STRIDES PHARMA SCIENCE  

Compare SHREE GANESH REMEDIES With:   VANTA BIOSCIENCE  SUNIL HEALTHCARE  NATCO PHARMA  ADVIK LABORS  STRIDES PHARMA SCIENCE  




Today's Market

4 Reasons Why Sensex Surged 514 Points Today(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a strong note.

Views on news

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

Cipla Shares Tank Despite Strong Earnings (Views On News)

Aug 6, 2021

The stock fell 3.5% even as the company reported numbers higher than analysts' expectations.

Glenmark Life Sciences Makes Lacklustre Debut. Shares List At 4% Premium (Views On News)

Aug 6, 2021

Glenmark Life Sciences' IPO had received strong response from investors as the offer was subscribed 44.17 times.

More Views on News

Most Popular

Sansera Engineering IPO: Key Points to Consider (Views On News)

Sep 8, 2021

This IPO is a pure OFS and the company is looking to raise Rs 12.8 bn at the upper price band of Rs 744.

5 Indian Companies that are Leading the AI Race (Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

The Top Stocks to Sell in this Bull Market (Profit Hunter)

Sep 8, 2021

When I saw the list of so-called 'value stocks' published by a leading brokerage, my worst fears came true.

5 Specialty Chemical Stocks that Turned Multibaggers in One Year (Views On News)

Sep 17, 2021

These specialty chemical stocks have surged 200% or more in the last year. Do you own any?

How to Create a Second Income from Trading (Profit Hunter)

Sep 10, 2021

My trading system that works in all kinds of markets.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SHREE GANESH REMEDIES

  • Track your investment in SHREE GANESH REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SHREE GANESH REMEDIES

SHREE GANESH REMEDIES - MANGALAM DRUGS COMPARISON

COMPARE SHREE GANESH REMEDIES WITH

MARKET STATS